Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
Recommendations from SCAI experts support the safety of PCI without on-site surgery
Read Full NewsTRN-257, a treatment in development for adults with narcolepsy and idiopathic hypersomnia, is designed to reduce daily sodium exposure relative to existing higher-sodium therapies.
The neurosurgeon at Cleveland Clinic discussed the goals of the AES thalamic neuromodulation special interest group and the major clinical and research priorities shaping the future of neuromodulation for drug resistant epilepsy.
A new study presented at AES 2025 reported that a cognitive-behavioral intervention via mobile application for patients with epilepsy can reliably capture daily self-reported outcomes.
A recent survey reveals fever significantly reduces seizure frequency in CDKL5 Deficiency Disorder, highlighting potential therapeutic strategies for patients.
New findings reveal bexicaserin significantly reduces seizure frequency in patients with developmental and epileptic encephalopathies, supporting its advancement to phase 3 trials.
Catch up on any of the neurology news headlines you may have missed in November 2025, compiled into 1 place by the NeurologyLive® team.
Patient Attitudes Key to Effective Hyperuricemia Self-Management
1.
Cancer death rates higher for children in neighborhoods with persistent poverty, study finds
2.
When a Groundbreaking Cancer Therapy Causes Cancer.
3.
An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.
4.
Mapping lifelong chronic health risks for childhood cancer survivors
5.
Study links persistent fatigue in breast cancer survivors to increased inflammation
1.
Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments
2.
The Benefits of Understanding Haptoglobin High: What You Need to Know
3.
Cancer Stem Cells: The Seeds of Tumorigenesis and Recurrence
4.
Unlocking the Mystery of Basilar Artery Stroke: A New Approach to Treatment
5.
Cemiplimab: A Revolutionary Drug For Treating Cancer
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
3.
Navigating the Complexities of Ph Negative ALL - Part IV
4.
Navigating the Complexities of Ph Negative ALL - Part VI
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge